Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Piñar-Morales

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Medicina Clinica|August 27, 2020
Bickerstaff encephalitis: Case reportRaquel Piñar Morales, Francisco Javier Barrero Hernández
Medicina Clinica|April 23, 2023
[Human prion diseases: An overview]Raquel Piñar-Morales, Francisco Barrero-Hernández, Luis Aliaga-Martínez
Case Reports in Neurology|March 30, 2022
Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Inflammatory Syndrome after Discontinuation of FingolimodRaquel Piñar Morales, María Carrasco Garcia, Luis Gutierrez-Rojas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Pharmacogenetics of siponimod: A systematic reviewXando Díaz-Villamarín, Raquel Piñar-Morales, Francisco Javier Barrero-Hernández, et al.
Frontiers in Pharmacology|May 1, 2025
Case Report: Neurofilament light chain in the follow up of progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with ocrelizumabRaquel Piñar-Morales, Raquel Calle-Calle, Maria Carrasco-Garcia, et al.
Scientific Reports|July 2, 2025
The impact of oxidative stress on symptoms associated with multiple sclerosisRaquel Piñar-Morales, Raquel Durán, Alicia Bautista-García, et al.
Patient Preference and Adherence|March 26, 2025
Clinical Practice Evidence of Treatment Satisfaction with Moderate and High-Efficacy Drugs in Multiple SclerosisFrancisco Javier Barrero Hernández, Ángel José Morales Lahoz, Cristina Serrano Gutiérrez, et al.
Journal of Personalized Medicine|July 27, 2024
Real-World Study of Serum Neurofilament Light Chain Levels in Ocrelizumab-Treated People with Relapsing Multiple SclerosisFrancisco J Barrero Hernández, Ana Romero Villarrubia, Carmen Muñoz Fernández, et al.
Journal of Personalized Medicine|November 26, 2025
Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and NeurodegenerationJosé María Barrios-López, Eva María Triviño-Ibáñez, Adrián Piñeiro-Donis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 11, 2024
Presentation and Outcome in S1P-RM and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: A Multicenter Cohort StudyJulie C Blant, Nicola N De Rossi, Ralf Gold, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Medicina Clinica|August 27, 2020
Bickerstaff encephalitis: Case reportRaquel Piñar Morales, Francisco Javier Barrero Hernández
Medicina Clinica|April 23, 2023
[Human prion diseases: An overview]Raquel Piñar-Morales, Francisco Barrero-Hernández, Luis Aliaga-Martínez
Case Reports in Neurology|March 30, 2022
Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Inflammatory Syndrome after Discontinuation of FingolimodRaquel Piñar Morales, María Carrasco Garcia, Luis Gutierrez-Rojas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2022
Pharmacogenetics of siponimod: A systematic reviewXando Díaz-Villamarín, Raquel Piñar-Morales, Francisco Javier Barrero-Hernández, et al.
Frontiers in Pharmacology|May 1, 2025
Case Report: Neurofilament light chain in the follow up of progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with ocrelizumabRaquel Piñar-Morales, Raquel Calle-Calle, Maria Carrasco-Garcia, et al.
Scientific Reports|July 2, 2025
The impact of oxidative stress on symptoms associated with multiple sclerosisRaquel Piñar-Morales, Raquel Durán, Alicia Bautista-García, et al.
Patient Preference and Adherence|March 26, 2025
Clinical Practice Evidence of Treatment Satisfaction with Moderate and High-Efficacy Drugs in Multiple SclerosisFrancisco Javier Barrero Hernández, Ángel José Morales Lahoz, Cristina Serrano Gutiérrez, et al.
Journal of Personalized Medicine|July 27, 2024
Real-World Study of Serum Neurofilament Light Chain Levels in Ocrelizumab-Treated People with Relapsing Multiple SclerosisFrancisco J Barrero Hernández, Ana Romero Villarrubia, Carmen Muñoz Fernández, et al.
Journal of Personalized Medicine|November 26, 2025
Baseline Findings from Dual-Phase Amyloid PET Study in Newly Diagnosed Multiple Sclerosis: Exploring Its Potential as a Biomarker of Myelination and NeurodegenerationJosé María Barrios-López, Eva María Triviño-Ibáñez, Adrián Piñeiro-Donis, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 11, 2024
Presentation and Outcome in S1P-RM and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: A Multicenter Cohort StudyJulie C Blant, Nicola N De Rossi, Ralf Gold, et al.
Pageof 2